Efficacy of praziquantel syrup versus crushed praziquantel tablets in the treatment of intestinal schistosomiasis in Ugandan preschool children, with observation on compliance and safety

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 106, Issue 7, 2012, Pages 400-407

  Navaratnam, A M D ^a   Sousa Figueiredo, J C ^b,c   Stothard, J R ^b   Kabatereine, N B ^d   Fenwick, A ^a   Mutumba Nakalembe, M J ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d MINISTRY OF HEALTH   (Uganda)

Author keywords

Child health; Control programmes; Mass drug administration; Neglected tropical diseases; Preventive chemotherapy; Schistosoma mansoni

Indexed keywords

ALBENDAZOLE; EPIQUANTEL; PRAZIQUANTEL; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ARTICLE; CHILD; CONTROLLED STUDY; COUGHING; DIARRHEA; DISEASE SEVERITY; DIZZINESS; DROWSINESS; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG SAFETY; EGG PARASITOID; FATIGUE; FEMALE; FEVER; HEADACHE; HEMATEMESIS; HEMATOCHEZIA; HEMATURIA; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; PATIENT COMPLIANCE; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; RASH; RECTUM HEMORRHAGE; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; SINGLE DRUG DOSE; SMEAR; SWELLING; SYRUP; TABLET; UGANDA; VOMITING;

ANTHELMINTICS; CHILD, PRESCHOOL; FECES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; NEGLECTED DISEASES; PARASITE EGG COUNT; PATIENT COMPLIANCE; PHARMACEUTICAL SOLUTIONS; PRAZIQUANTEL; QUESTIONNAIRES; SCHISTOSOMIASIS MANSONI; TABLETS; TREATMENT OUTCOME; UGANDA;

SCHISTOSOMA MANSONI;

EID: 84862145532     PISSN: 00359203     EISSN: 18783503     Source Type: Journal    
DOI: 10.1016/j.trstmh.2012.03.013     Document Type: Article

References (28)

1. WHO. Schistosomiasis. Geneva: World Health Organization; [accessed 2 November 2010]. http://www.who.int/schistosomiasis/en/.
2. Kabatereine N.B., Brooker S., Tukahebwa E.M., Kazibwe F., Onapa A.W. Epidemiology and geography of Schistosoma mansoni in Uganda: implications for planning control. Trop Med Int Health 2004, 9:372-380.
3. Kabatereine N.B., Tukahebwa E., Kazibwe F., et al. Progress towards countrywide control of schistosomiasis and soil-transmitted helminthiasis in Uganda. Trans R Soc Trop Med Hyg 2006, 100:208-215.
4. Kabatereine N.B., Fleming F.M., Nyandindi U., Mwanza J.C.L., Blair L. The control of schistosomiasis and soil-transmitted helminths in East Africa. Trends Parasitol 2006, 22:332-339.
5. Mott K.E. 'Control of schistosomiasis': morbidity-reduction and chemotherapy. Acta Leiden 1982, 49:101-111.
6. Fleming F.M., Fenwick A., Tukahebwa E.M., et al. Process evaluation of schistosomiasis control in Uganda, 2003 to 2006: perceptions, attitudes and constraints of a national programme. Parasitology 2009, 136:1-11.
7. Johansen M.V., Sacko M., Vennervald B.J., Kabatereine N.B. Leave children untreated and sustain inequity!. Trends Parasitol 2007, 23:568-569. author reply 569-70.
8. Odogwu S.E., Ramamurthy N.K., Kabatereine N.B., et al. Schistosoma mansoni in infants (aged <3 years) along the Ugandan shoreline of Lake Victoria. Ann Trop Med Parasitol 2006, 100:315-326.
9. Montresor A., Stoltzfus R.J., Albonico M., et al. Is the exclusion of children under 24 months from anthelmintic treatment justifiable?. Trans R Soc Trop Med Hyg 2002, 96:197-199.
10. Sousa-Figueiredo J.C., Pleasant J., Day M., et al. Treatment of intestinal schistosomiasis in Ugandan preschool children: best diagnosis, treatment efficacy and side-effects, and an extended praziquantel dosing pole. Int Health 2010, 2:103-113.
11. Mutapi F., Rujeni N., Bourke C., et al. Schistosoma haematobium treatment in 1-5 year old children: safety and efficacy of the antihelminthic drug praziquantel. PLoS Negl Trop Dis 2011, 5:e1143.
12. Sousa-Figueiredo J.C., Day M., Betson M., et al. Field survey for strongyloidiasis in eastern Uganda with observations on efficacy of preventive chemotherapy and co-occurrence of soil-transmitted helminthiasis/intestinal schistosomiasis. J Helminthol 2011, 85:325-333.
13. Cioli D., Pica-Mattoccia L. Praziquantel. Parasitol Res 2003, 90(Suppl 1):S3-S9.
14. Doenhoff M.J., Hagan P., Cioli D., et al. Praziquantel: its use in control of schistosomiasis in sub-Saharan Africa and current research needs. Parasitology 2009, 136:1825-1835.
15. Kazibwe F., Makanga B., Rubaire-Akiiki C., et al. Transmission studies of intestinal schistosomiasis in Lake Albert, Uganda and experimental compatibility of local Biomphalaria spp. Parasitol Int 2010, 59:49-53.
16. Hall A., Nokes C., Wen S.T., et al. Alternatives to bodyweight for estimating the dose of praziquantel needed to treat schistosomiasis. Trans R Soc Trop Med Hyg 1999, 93:653-658.
17. Katz N., Chaves A., Pellegrino J. A simple device for quantitative stool thick-smear technique in schistosomiasis mansoni. Rev Inst Med Trop Sao Paulo 1972, 14:397-400.
18. Armitage P., Berry G. Statistical methods in medical research 1994, Blackwell Scientific Publications, Oxford, UK.
19. Fisher R.A. On the interpretation of chi-square from contingency tables and the calculation of P. J R Stat Soc 1922, 85:87-94.
20. Obonyo C.O., Muok E.M., Mwinzi P.N. Efficacy of artesunate with sulfalene plus pyrimethamine versus praziquantel for treatment of Schistosoma mansoni in Kenyan children: an open-label randomised controlled trial. Lancet Infect Dis 2010, 10:603-611.
21. Kabatereine N.B., Kemijumbi J., Ouma J.H., et al. Efficacy and side effects of praziquantel treatment in a highly endemic Schistosoma mansoni focus at Lake Albert, Uganda. Trans R Soc Trop Med Hyg 2003, 97:599-603.
22. Xiao S.H., Catto B.A., Webster L.T. Effects of praziquantel on different developmental stages of Schistosoma mansoni in vitro and in vivo. J Infect Dis 1985, 151:1130-1137.
23. Berhe N., Medhin G., Erko B., et al. Variations in helminth faecal egg counts in Kato-Katz thick smears and their implications in assessing infection status with Schistosoma mansoni. Acta Trop 2004, 92:205-212.
24. Montresor A. Cure rate is not a valid indicator for assessing drug efficacy and impact of preventive chemotherapy interventions against schistosomiasis and soil-transmitted helminthiasis. Trans R Soc Trop Med Hyg 2011, 105:361-363.
25. Gryseels B., Nkulikyinka L., Coosemans M.H. Field trials of praziquantel and oxamniquine for the treatment of schistosomiasis mansoni in Burundi. Trans R Soc Trop Med Hyg 1987, 81:641-644.
26. Berhe N., Gundersen S.G., Abebe F., Birrie H., Girmay M., Teferi G. Praziquantel side effects and efficacy related to Schistosoma mansoni egg loads and morbidity in primary school children in north-east Ethiopia. Acta Trop 1999, 72:53-63.
27. Doenhoff M.J., Cioli D., Utzinger J. Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis. Curr Opin Infect Dis 2008, 21:659-667.
28. Olliaro P.L., Vaillant M.T., Belizario V.J., et al. A multicentre randomized controlled trial of the efficacy and safety of single-dose praziquantel at 40 mg/kg vs. 60 mg/kg for treating intestinal schistosomiasis in the Philippines, Mauritania, Tanzania and Brazil. PLoS Negl Trop Dis 2011, 5:e1165.